Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2008-11-21

Specific Compartmentalization of IgA ASCs in Mouse Salivary
Glands via Differential Expression of Chemokines and Chemokine
Receptors
Yuet Ching Law
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Microbiology Commons

BYU ScholarsArchive Citation
Law, Yuet Ching, "Specific Compartmentalization of IgA ASCs in Mouse Salivary Glands via Differential
Expression of Chemokines and Chemokine Receptors" (2008). Theses and Dissertations. 1952.
https://scholarsarchive.byu.edu/etd/1952

This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion
in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please
contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

SPECIFIC COMPARTMENTALIZATION OF IMMUNOGLOBULIN A
ANTIBODY SECRETING CELLS IN MOUSE SALIVARY GLANDS
VIA THE DIFFERENTIAL EXPRESSION OF CHEMOKINES AND
CHEMOKINE RECEPTORS

by
Yuet Ching Law

A thesis submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree of

Master of Science

Department of Microbiology and Molecular Biology
Brigham Young University
December 2008

Copyright © 2008 Yuet Ching Law
All Rights Reserved

BRIGHAM YOUNG UNIVERSITY

GRADUATE COMMITTEE APPROVAL

of a thesis submitted by
Yuet Ching Law
This thesis has been read by each member of the following graduate committee and by
majority vote has been found to be satisfactory.

Date

Dr. Eric Wilson, Chair

Date

Dr. Gregory F. Burton

Date

Dr. David L. Erickson

BRIGHAM YOUNG UNIVERSITY

As chair of the candidate’s graduate committee, I have read the thesis of Yuet Ching Law
in its final form and have found that (1) its format, citations, and bibliographical style are
consistent and acceptable and fulfill university and department style requirements; (2) its
illustrative materials including figures, tables, and charts are in place; and (3) the final
manuscript is satisfactory to the graduate committee and is ready for submission to the
university library.

Date

Eric Wilson
Chair, Graduate Committee

Accepted for the Department
Date

Brent Nielsen
Department Chair

Accepted for the College

Date

Rodney J. Brown
Dean, College of Life Science

ABSTRACT

SPECIFIC COMPARTMENTALIZATION OF IMMUNOGLOBULIN A
ANTIBODY SECRETING CELLS IN MOUSE SALIVARY GLANDS
VIA THE DIFFERENTIAL EXPRESSION OF CHEMOKINES AND
CHEMOKINE RECEPTORS

Yuet Ching Law
Department of Microbiology and Molecular Biology
Master of Science

The mucosal system, which forms a barrier between internal organ systems and
the external environment, is frequently exposed to pathogenic microorganisms.
Immunoglobulin A (IgA) antibody secreting cells (ASCs) localize in the lamina propria,
and produce IgA antibodies which help protect mucosal tissues. The concept of a
common mucosal immune system in which IgA ASCs have the ability to populate any
mucosal site has been proposed (1, 2). However, recent research has suggested that IgA
ASCs primed in different mucosal sites might possess different sets of chemokine
receptors, and therefore migrate specifically to particular mucosal locations (3). In this
study, the specific compartmentalization of IgA ASCs in two mouse salivary glands:

sublingual gland (SLG), and submandibular gland (SMG) was studied. It was observed
that SLG had 12 times more IgA ASCs per gram of gland than that of SMG (p<0.01).
This suggested that IgA ASCs migrated to the two salivary glands with different
efficiencies. Since the migration of lymphocytes is mediated by interactions between
tissue specific chemokines and chemokine receptors, I hypothesized that the specific
compartmentalization of IgA ASCs in the SLG and SMG was mediated by the differential
expression of IgA ASC attracting chemokines. Quantitative PCR was used and showed
that SLG expressed high levels of CCL28 and its receptor CCR10, which correlated to the
distribution of IgA ASCs in the two salivary glands. In agreement with QPCR data,
reduced levels of IgA ASCs were found in the SLG of CCR10 deficient mice when
compared to wild type (WT) mice. Adoptive transfer of CCR10 deficient mice with WT
spleen cells reconstituted the WT phenotype. It was therefore concluded that the
interaction between CCL28 and CCR10 play an important role in mediating the migration
of IgA ASCs into SLG. These results suggested that the accumulation of IgA ASC to
distinct salivary glands is a highly selective process. These data also suggested that
homing within mucosal sites is not common but rather a highly regulated process with
specific subsets of cells homing to different tissues within the mucosal immune system.
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INTRODUCTION
Immune System
The immune system is a complex network of cells and organs in the body that
provides protection against invading pathogens. The immune system protects the body
through both innate and adaptive mechanisms. Adaptive immunity generates the
“memory” of the immune system in which a more rapid and vigorous immune response
results in a subsequent exposure to an antigen. Self and non-self recognition is another
characteristic of the immune system in which, ideally, only foreign object are attacked.
The cells of the immune system originate in the bone marrow. Lymphocytes then
migrate to the primary lymphoid organs where they develop before migrating to the
secondary lymphoid tissues (SLT). In the SLT, lymphocytes are activated by contact
with antigens and undergo further differentiation. B cells originate and mature in bone
marrow, while immature T cells migrate to the thymus for maturation. After maturation,
the naïve lymphocytes recirculate through the lymph nodes, spleen, and mucosal
associated lymphoid tissues (MALT) continually to encounter foreign antigens.
Lymphocytes activated in the MALT become part of the mucosal immune system, which
provide protection to the mucosal surfaces (4).
Mucosal Immune System
The mucosal system consists of the nasal, bronchial, gastrointestinal and
urogenitinal tracts, as well as the lachrymal, salivary, mammary glands, and the
synovium of joints (5). The large surface area of the mucosal system is the entry site of
many pathogens. It is, therefore, important that the mucosal tissues are protected by the
immune system. The MALT comprises the mucosal immune system and protects the
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mucosal tissues with both humoral and cell mediated immunity. The MALT is usually
divided into several components according to the anatomical locations. They are the gut
associated lymphoid tissue (GALT), the bronchus associated lymphoid tissue (BALT),
the nasopharynx associated lymphoid tissues (NALT), the mammary glands and the
genitourinary lymphoid tissues (6). Among all the components of MALT, GALT is the
largest and most extensively studied. GALT consists of the Peyer’s patches (PP),
appendix and mesenteric lymph nodes (MLN), and submucosal lymphoid follicles. It is
estimated that GALT contains up to 80% of the body’s immunoglobulin producing cells
(7).
On the surface of the gastrointestinal (GI) tract resides a specialized epithelial cell
type called M cells. These cells bind to and transcytosis foreign antigens to the
conjugated MALT. The antigens transported to the subepithelial dome region in the
GALT interact with immune cells including dendritic cells, macrophages, T and B cells.
The B cells activated in this germinal follicle generally become IgA producing cells,
which are responsible for secreting immunoglobulin in all the mucosal sites. These IgA
committed B cells, however, do not developed into plasma cells within the germinal
center (GC) in the PP. But rather leave the GC, migrate to draining lymph nodes and
home to the lamina propria at mucosal sites, where they are further activated by cytokines,
mainly TGF-β, secreted by Th2 cells. Here the activated B cells will fully differentiate
into plasma cells and produce dimeric IgA for secretion (8).
Secretory IgA (SIgA) is the predominant immunoglobulin that protects mucosal
tissues. Mucosal sites are frequently exposed to pathogens, so interactions between
antibody and antigen are constantly occurring and optimal immune protection is vital.
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Secretory IgA, which lacks the ability to activate complement, protects these tissues by
binding to pathogens, blocking the adhesion of pathogens to the mucosal surface, and
preventing the penetration of antigens into the internal environment. This binding also
prevents the over stimulation of the immune system, which may result in extensive
inflammation in the mucosal sites (9). In addition, SIgA also protects the mucosae by
neutralizing toxins and inactivating harmful enzymes (10).
In order to protect mucosal tissues, IgA is secreted through the epithelial layer of the
mucosal surfaces. IgA antibodies are synthesized in dimeric form with a J chain
connecting the two monomers. The J chain allows the transcytosis of IgA across the
mucosal epithelium by binding to the poly-Ig receptor (pIgR) on the basolateral surfaces
of the epithelial cells. After transcytosis, the ligand-binding region of pIgR is
enzymatically cleaved from the cell and becomes the secretory component (SC) of the
secreted IgA. SC has anti-microbial properties and is also important in protecting the
IgA dimer from proteolytic cleavage (11).
Human IgA is grouped into two subclasses (IgA1 and IgA2), while the mouse only
has a single isoform of IgA. The proportions of the two human IgA subclasses vary
among different mucosal sites. The distal gastrointestinal tract is predominantly
protected by IgA2; whereas IgA1 is the major IgA subclass at salivary glands and nasal
associated lymphoid tissue (5). The distribution of the two IgA subclasses generally
reflects the local antigen types (proteins or polysaccharides) IgA ASCs encountered.
IgA1 is the predominant subclass in humans and is often generated in response to protein
antigens, while IgA2 antibodies often bind polysaccharides (12).

3

To study the ontogeny of the mucosal immune system in human, many researchers
have used the level of salivary immunoglobulins. It was believed that salivary glands are
part of the common mucosal immune system and the antibodies levels in the saliva are
representative of mucosal immune competence (13). Collection of saliva is simple and
non-invasive, and the secretion can be easily analyzed by routine laboratory procedures.
Therefore saliva has long been used to monitor the mucosal immune system (5, 13-17).
Based on the analysis of saliva, detection of SIgA has been reported to be as early as
at birth, although most researchers agree that secretion of SIgA begins between 1 week
and 2 months of age (18). During the first few weeks of life, salivary IgA levels increase
rapidly and peak at 4 to 6 weeks of age. The initial peaks of salivary SIgA slowly decline
to lower levels between 3 and 6 months of age and are believed to reach adult salivary
SIgA levels at around 7 years of age. Interestingly, at birth, the proportion of the two IgA
subclasses is different from adulthood, even though IgA1 remains the predominant
subclass. At birth, almost 90% of the salivary SIgAs are of IgA1, which decreases to
around 60% in first 3 months of life to approach adult proportions (19). The decline of
the IgA1 proportion may be the result of changes in antigen type and load after birth,
when more polysaccharide based antigens are introduced.
Common Mucosal Immune System
The concept of a common mucosal immune system involves an interconnective
network within the mucosal immune system to provide effective protection to all mucosal
tissues. In theory this would provide a mechanism by which immunization to a single
mucosal site would provide protection to all mucosal tissues. This hypothesis is based on
data showing that immunization in one mucosal site would not only induce a response at
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the site of antigen encounter, but also in remote mucosal surfaces and exocrine glands. It
was observed that after oral immunization, IgA antibodies specific for the antigen were
detected not only in the gut, but also in the bronchial tract, the salivary, lachrymal and
mammary glands (20). It has also been demonstrated that cells from the BALT can
repopulate the spleen, bowel and lung of lethally irradiated rabbits with IgA ASCs (2).
Vice versa, IgA ASCs from GALT had similar ability to repopulate the bronchial mucosa
(21). Adoptive transfer of the precursors of the IgA plasmacytes from PP reconstituted
the gut and bronchus of allogenic or autologous irradiated hosts. Other adoptive transfer
experiments by McDermott et al. (20) also showed that thymidine-labeled donor MLN
cells migrated to recipient gut, cervix and vagina, uterus, mammary glands, and MLN.
Goldblum et al. (22) hypothesized that IgA ASCs originating in the intestinal tract
have the capacity to migrate to other mucosal site, which may explain the phenomenon of
the common mucosal immune system. They showed that antigen specific IgAs for nonpathogenic E. coli appeared in mammary gland secretion of lactating females after oral
feeding of the bacteria. The migration of IgA ASCs from the intestinal mucosa into the
mammary gland results in the secretion of SIgA specific for antigens found the mother’s
intestine, which the infant will most likely encounter. In the newborn, which has an
immature immune system and a not fully developed intestine, the passive immunity
received from breastmilk provides important protection. The importance of breastmilk
antibody is also supported by the studies of Weisz-Carrington et al. (23), in which they
showed that oral immunization of ferritin resulted in IgA ASCs localized in lactating
mammary gland, salivary glands, and respiratory tract. They further confirmed this
theory by showing that adoptively transferred ferritin-specific IgA ASCs from mesenteric
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lymph node homed to exocrine glands of nonimmunized recipients (23). All these
evidence suggested that there is a common mucosal immune system.
Homing of Lymphocytes and Chemokines
Lymphocyte trafficking into specific tissues is critical in maintaining normal
homeostasis of the immune system. Many aspects of the immune system depend on the
proper homing of leukocytes. These range from naïve T and B cells homing to lymph
nodes for activation to the homing and accumulation of leukocytes to sites of infection
and inflammation. Autoimmune diseases might result when activated lymphocytes home
to inappropriate locations and exert immune responses. For example, when lymphocytic
infiltration develops in the salivary glands due to the expression of homing signals,
Sjögren’s syndrome occurs. Inflammatory bowel disease is the result of aberrant
activation of both innate and adaptive immune responses in the gastrointestinal tract (24),
while rheumatoid arthritis is the condition when the immune system is activated and
attacks the joints. Therefore the homing and migration of lymphocytes must be strictly
regulated. It is known that the homing of lymphocytes is mediated by a cascade of
interactions, including the interactions between chemokines and adhesion molecule
ligands secreted or expressed by tissues, and chemokine receptors and the adhesion
molecules expressed by the lymphocytes. Chemokines, which are small protein
chemoattractant cytokines (~12kDa), can be called the organizers of the immune system
as they promote the specific localization of lymphocytes into distinct parts in the body.
Members of this family have conserved amino acid sequences and their receptors are G
protein coupled seven trans-membrane helices (25).
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Chemokines are grouped and named by the number and location of the conserved N
terminal cysteines. There are four groups of chemokines: first, the CC chemokines,
which have two adjacent cysteines at the amino end; second, the CXC chemokines with
the two cysteines separated by a single amino acid; third, the C chemokines, which has
only one conserved cysteine at the amino terminus; and the last group CX3C chemokines,
which the two N terminus cysteines are separated by three amino acids. These
chemokines act on different sets of receptors to orchestrate lymphocyte migration. There
are ten known CC receptors (CCR), designated CCR1-10, and they bind to CC
chemokines CCL1-28. CXC chemokines 1-16, on the other hand, bind to CXCR1-6 (25).
After binding to their cognate receptors, chemokines, exert their functions in two
steps: first, they increase the binding avidity of the adhesion molecule integrin receptors
expressed on the lymphocyte membrane allowing firm adhesion of the lymphocyte.
Second, chemokines are also thought to be involved in lymphocyte extravasation and
migration via concentration gradients of the chemokine molecules (4). Extravasation of
lymphocytes out of blood vessels occurs in four steps. The first step is the rolling step
and selectins are involved. Selectins are glycoproteins that are expressed on both
endothelium and the lymphocyte membrane. Selectins bind to heavily glycosylated
molecules such as mucins to promote the adhesion and rolling of lymphocytes along the
epithelium. This interaction is not strong enough to stop the lymphocyte, but allows the
lymphocyte to slow down for the activation in the second step. In the normal state,
lymphocytes express integrins with low binding avidity to endothelium expressed cell
adhesion molecules (CAMs). In the presence of appropriate chemokines, integrins on the
lymphocyte that express the cognate chemokine receptors exert conformational changes,
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resulting in firm attachment to the endothelial wall and rolling is arrested. In the third
step, lymphocytes diapedese across the endothelial wall, which is, again, mediated by the
interactions between the integrins and adhesion molecules expressed on the lymphocyte
and the endothelial cells. In the forth step the lymphocyte migrates toward the source of
the chemokine (4).
As understanding of the lymphocyte migration process increases, the molecular
nature of homing to mucosa tissue is being better understood. It has been shown that gut
associated mucosal venules express the mucosal addressin MAdCAM-1, which is an
immunoglobulin superfamily adhesion molecule. MAdCAM-1 has been shown to bind
α4β7 integrin expressing lymphocytes and mediate homing to mucosal surfaces (26).
Two main sets of mucosal attracting chemokines and their receptors have also been
identified, these are CCL28 and its receptor CCR10; and CCL25 and its receptor CCR9
(3). Some IgA ASCs have also been shown to respond to CXCL12, which binds to
receptor CXCR4.
CCL28 and CCR10
CCL28, also known as mucosae-associated epithelial chemokine (MEC), is a
potent chemoattractant for CCR10 expressing IgA ASCs (3, 27). CCL28 is also called “a
common mucosal chemokine” by Lazarus et al. (27) because it selectively attracts IgA
ASCs, but not IgG or IgM ASCs, into almost all mucosal surfaces. CCL28 exerts its
function by enhancing the α4 integrin dependent adhesion of IgA ASCs to MAdCAM-1
and vascular CAM-1 (VCAM-1), which are expressed in various mucosal sites (3).
CCL28 is secreted at high levels by epithelial cells in various mucosal tissues including
the salivary gland, colon, lactating mammary glands, and bronchial tissues (28-30).
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Expression of CCL28 in small intestine has also been reported and anti-CCL28 blocking
antibody can prevent the homing of IgA ASCs into both small and large intestine (3).
Among all the mouse mucosal tissues, salivary glands have the highest CCL28
mRNA level, as determined through dot blot and Northern blot analysis methods (30).
Immunohistochemistry also shows that salivary glands express high level of CCL28,
which correlates with the findings that high concentrations of CCL28 are found in human
saliva (28). The high expression of CCL28 in salivary glands may mediate the migration
of IgA ASCs into this mucosal site. It has been shown that IgA ASCs from mouse
parotid glands, which is one of the major salivary glands, express CCR10 at high levels
and respond to CCL28 in chemotaxis assays (28). These findings suggest that CCL28
may be important in attracting IgA ASCs to the two mouse salivary glands in vivo.
CCL25 and CCR9
CCL25, a CCR9 chemokine ligand, is selectively secreted by the thymus and
small intestinal epithelial cells (31). Another name for CCL25 is thymus-expressed
chemokine (TECK) as it is a chemoattractant for circulating and resident gut-homing T
cells (32). It has been demonstrated that IgA ASCs from the spleen, intestinal lymphoid
tissues, and the small intestine respond and migrate to CCL25 in chemotaxis assays (33).
This suggests that CCR9 is probably induced during the development of IgA ASCs in the
GALT. Similar to CCL28, CCL25 can also promote the adhesion of IgA ASCs to
MAdCAM-1 and VCAM-1, which is important in the extravasation of IgA ASCs into the
intestinal lamina propria (3). Although CCL25 is not highly expressed in mucosal tissues
other than the small intestine (31), its ability in attracting IgA ASCs should not be
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ignored, as it may also contribute in the specific homing of IgA ASCs into other mucosal
tissues.
CXCL12 and CXCR4
CXCR4 and its ligand CXCL12, also known as stromal cell-derived factor 1 (SDF1), is important in the localization of plasma cells in the splenic red pulp and in the bone
marrow (34). It has been reported that IgA ASCs in both small and large intestine
express CXCR4, and some IgA ASCs migrate to CXCL12 (3). CXCL12 can activate
VCAM-1 binding to the integrin α4β1. Glodek et al. (35) showed that CXCL12
promotes the sustained activation of α4β1 in immature B cells in bone marrow, but not in
mature, peripheral circulating B cells, and prevents the premature release of B cell
precursors from bone marrow.
Unique IgA ASCs Migration Patterns
The differential secretion of CCL25 and CCL28 by mucosal tissues may promote
the migration of antigen-specific IgA ASCs after oral or nasal immunization. For
example, after oral immunization, antigen-specific IgA ASCs are detected in both
intestinal and non-intestinal mucosal tissues, such as salivary glands, respiratory tract,
and the mammary glands (36). However, after nasal immunization, distribution of
antigen-specific IgA ASCs is only restricted the upper aerodigestive tract and the
urogenital tract (37, 38). These results suggest that the differential expression of
chemokines may contribute to the specific compartmentalization of IgA ASCs in the
salivary glands.
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Salivary Glands
In mammals, salivary glands are exocrine glands that produce saliva. There are
three major pairs of salivary glands; they are the parotid glands, the submandibular
glands (SMG), and the sublingual glands (SLG). In humans, they are located at different
places in the mouth and the secretions from the three salivary glands are chemically
different. Saliva consists of serous and mucous fluids. The serous fluid contains amylase
to digest carbohydrates, and the mucous fluid serves as lubricant. In humans the parotid
glands are the largest and they are located in the subcutaneous tissues of the face
overlying the mandibular ramus and anterior and inferior to the external ear. Parotid
glands produce almost purely serous saliva. SMG are located beneath the floor of the
mouth and secrete a mixture of serous and mucous saliva. SLG are located anterior to the
SMG, and the secretion is mainly mucous in nature (39).
IgA ASCs in Pig Tonsils and Mouse Salivary Glands
In the pig, the pharyngeal (Ph) and palatine (Pa) tonsils are located in different
regions of the upper aerodigestive tract and form part of the Waldeyer’s ring. It was
previously believed that they played redundant roles in protecting the respiratory tract.
However it has recently been observed that one of the tonsils has more abundant IgA
ASCs (40). After intranasal immunization, antibody secreting cell response was induced
in the Ph tonsil but not in the Pa tonsil, suggesting that these two tonsils may represent
different compartments in the mucosal immune system (41). Analysis of the chemokines
and adhesion molecules in these tissues revealed the differential expression of CCL28
and VCAM-1 in the two tonsils, where Ph expressed higher concentrations of both of the
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adhesion molecules. The results correlated with differential compartmentalization of IgA
ASCs in the tissues (40).
Being part of the mucosal system, the salivary glands produce large amount of
IgA antibodies. However, not much is known about the specific localization of IgA
ASCs in the salivary glands and the migration events of IgA ASCs into the glands have
not been described. Similar to the pig tonsils, I found that the concentration of IgA ASCs
in one of the mouse salivary glands, the SLG, was surprisingly higher than that of in the
SMG. Since the localization pattern of IgA ASCs in the two mouse salivary glands were
very similar to the pig tonsils, I hypothesized that the differential expression of epithelial
chemokines (CCL28 and CCL25) and addressins (MAdCAM-1 and VCAM-1) controls
the specific localization of the IgA ASCs into distinct mucosal sites. In this thesis, the
distribution of IgA ASCs in the two mouse salivary glands was shown and its correlation
with the mucosal attracting chemokines, chemokine receptors, and adhesion molecule
levels was analyzed. My results demonstrated that CCR10 and its ligand CCL28 were
expressed at high levels in SLG, which correlated with high numbers of IgA ASCs in the
salivary gland. CCR10 knock out (KO) mice, which are deficient in the CCL28 receptor
CCR10, had less IgA ASCs localized in SLG when compared with WT mice. CCR10KO
mice adoptive transferred with WT cells reconstituted the SLG with high levels of IgA
ASCs but not the SMG. Together these results suggest that differential expression of
chemokines and chemokine receptors contributed to the distinct migration patterns of IgA
ASCs into salivary tissues.
It has previously been suggested that the salivary glands are part of the common
mucosal immune system and that the IgA ASCs within this system should migrate
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equally well to all mucosal tissues. Here, I demonstrated the differential expression of
CCL28 mediated the specific localization of IgA ASCs in the mouse SLG but not the
SMG. These results suggest that migration within the mucosal immune system is not
common but in some cases is highly specific to individual glands. Understanding the
mechanisms of IgA ASC localization into specific tissues has important implication in
the design and use of mucosal vaccines, as well as increasing our understanding of the
basic science of lymphocyte homing and migration.
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MATERIALS AND METHODS
Immunohistology
Salivary gland samples were collected from animals upon necropsy and frozen in
OCT freezing medium (Tissue-Tek, Elkhart, IN). For immunohistology, 8µm frozen
sections were air dried, fixed in cold acetone for 10 minutes and stained with FITC
labeled anti-IgA (Clone C10-3), APC labeled anti-CD4 (clone GK1.5) and PE labeled
anti-CD45R (clone RA3-6B2). Staining was visualized using confocal microscopy.

RNA collection and analysis
Sublingual and submandibular salivary glands were collected from mice. RNA
was extracted from the samples using TRIZOL reagent according to manufactures
instructions (Invitrogen Carlsbad, California). Quantitative PCR (QPCR) was performed
in duplicate on each sample using a Verso 1-step QRT-PCR ROX kit (Thermo Fisher
Scientific, Waltham, MA), with 1 cycle of cDNA synthesis at 50oC for 15 min, 1 cycle of
Thermo-Start activation at 95 oC for 15 min, then 40 cycle of denaturation at 95 oC for 15
sec and annealing/extension at 60 oC for 60 sec. GAPDH specific primers with VICMGB probe were used as an endogenous control. Primer and probe for the IgA constant
region, chemokines (CCL28, CCL25, CXCL12, and VCAM), and the chemokine
receptors (CCR10 and CCR9) were designed and manufactured by Applied Biosystems,
Foster City, CA. All the primers were used in conjunction with FAM labeled probe.
QPCR assays were performed on an Applied Biosystems 7300 Real-Time PCR System
and the results were analyzed using Relative Quantification software from Applied
Biosystems. This software generated amplification curves of the endogenous control

14

(GAPDH) and these values are then used to standardize any differences in RNA
concentrations between samples.
IgA mRNA levels from all the salivary gland samples were assessed by assigning
the IgA mRNA level in the submandibular gland of each mouse to an arbitrary value of 1
and then comparing the IgA mRNA level from the sublingual gland of the same mouse.
Differences are determined as fold increase or decrease to this calibrator sample. The
resultant values from WT, CCR10KO and adoptive transferred CCR10KO mice were
averaged separately.
Chemokines and the chemokine receptor mRNA levels were measured and
compared from 8 WT mice using the same calibration method as with IgA mRNA levels.

Isolation of protein from salivary glands
Sublingual and submandibular salivary glands from 3 to 6 month old female mice
were collected and immediately placed in round bottom tubes in ice. Samples not used
immediately were stored in -80oC for future protein extraction. Brij 150 lysis buffer (1ml
1M Tris, 0.4ml 0.5M EDTA, 3ml 5M NaCl, 8.75ml Brij 96 10%, 1.25ml NP40 10%,
85.6ml H2O) with protease inhibitors was added into the tubes with approximately 1ml
Brij buffer per each 100µl tissue volume. The samples were then homogenized into the
buffer and transferred into 1.5ml Eppendorf tubes, followed by centrifugation in 4oC at
full speed. Supernatants containing the protein were transferred into new Eppendorf
tubes and stored at -20oC in a non-frost-free freezer. The protein samples were used in
both ELISA and Bradford assays.
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ELISA
ELISA plates (Nun International, Rochester, NY) were incubated overnight at 4oC
with 50 µl of 2µg/ml anti-mouse IgA antibody (clone C10-3, BD Pharmingen) for IgA
ELISA or cholera toxin for antigen specific ELISA. Wells were washed 3 times with
PBS and incubated for 1/2 hr at RT with 200 µl blocking buffer (0.17M boric acid,
0.12M sodium chloride, 0.05% Tween 20, 1mM EDTA, 0.25% BSA, 0.05% sodium
azide). Wells were again washed 3 times and incubated for 1 hr at RT with serial
dilutions of 100 µl 1:2 diluted protein samples in blocking buffer or 1:1000 diluted
reference mouse IgA antibody (M18-254, BD Pharmingen). After 3 washes, wells were
incubated for 1 hr at RT with 100 µl 1:1000 diluted AP-goat anti-mouse IgA (Zymed).
Wells were washed 6 times and incubated with 50 µl AP substrate solution
(SouthernBiotech). The plates were read at OD 405 nm. Total IgA concentrations in
each protein sample were determined by constructing a standard curve of the known
values. Concentrations of antigen specific IgA were represented as absorbance at OD
405 nm.

Bradford protein assay
Total protein levels from the extracted samples were determined by Bradford
assay. 4µl extracted protein samples and known concentrations of BSA samples were
mixed with 200µl Bradford reagent in 750µl Eppendorf tubes at RT. 2 µl of the mixtures
were then loaded onto NanoDrop ND-1000 (NanoDrop Technologies) and read at 280nm.
Total protein contents in the samples were determined by comparing with the standard
curve of the BSA samples.
16

IgA content
To normalize for the effect of unequal amounts of protein extracted in each
sample, IgA content in each sample was represented as pg of IgA (calculated from
ELISA assay) per µg of total protein. Resultant values from sublingual and
submandibular glands of WT, CCR10KO, and CCR10KO mice received adoptive
transferred were averaged and standard error of the mean were determined.

CCR10KO adoptive transfer
CCR10KO mice were developed by and obtained from Olivier Morteau
(Perlmutter Laboratory and Department of Pediatrics, Children's Hospital, Harvard
Medical School, Boston, Massachusetts 02115, USA). Spleen cells from 5 female WT
mice and 5 female CCR10KO mice were collected separately by mashing spleens
between two microscope slides. The slides were washed with RPMI-1640 medium
(HyClone) and the cells-RPMI mixtures were filtered through nylon into 15ml centrifuge
tubes. The tubes were then centrifuged at 1700 rpm for 5 minutes. Supernatants were
discarded and the cell pellets were diluted with RPMI to 2.0x108 cells/ml. 5 CCR10KO
mice were injected intraperitoneally with 200 µl WT spleen cells and another 5
CCR10KO mice were injected with 200ul CCR10KO spleen cells as controls. The 10
adoptively transferred mice were sacrificed 2 weeks following adoptive transfer and their
sublingual and submandibular glands were collected. RNA and protein were extracted
from the salivary glands for analysis of IgA levels by QPCR and IgA protein levels.
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Oral and nasal cholera toxin immunization
For oral cholera toxin (CT) immunization, 7 mice were deprived from food and
water 2 hours prior to the immunization. Then 250µl of sodium bicarbonate solution (8
parts HBSS to 2 parts 7.5% sodium bicarbonate) was administered orally to the mice.
Half an hour later, the mice were orally immunized with 250µl CT solution (10µg CT in
250µl PBS). For nasal immunization, 10µl CT solution (10µg CT in 10µl PBS) was
pipetted into nasal cavities of 6 WT mice. The two groups of mice were boosted with CT
2 weeks after the first immunization and they were sacrificed 2 weeks following the
second immunization. Total protein was extracted from the salivary glands of the two
immunized group for ELISA and Bradford assays.
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RESULTS
IgA ASCs selectively accumulated in the SLG when compared to the SMG
Immunohistological analysis of sections of the salivary glands from WT mice
revealed that there were higher concentrations of IgA ASCs localized in sublingual
glands when compared with the submandibular gland (Figure 1). To confirm this finding
and to measure the amount of IgA in the two salivary glands quantitatively, QPCR was
used. Primers for IgA ASCs were designed from the constant region of IgA, which
should only be expressed by IgA ASCs. IgA mRNA levels as determined by QPCR
provided measurement of the amount of IgA in the two salivary glands. The IgA QPCR
results from 8 female mice showed that sublingual gland contained 12 times more IgA
mRNAs than submandibular gland (p=0.00314) (Figure 2). All the samples were run in
duplicate.
Levels of mRNA expressions do not always represent the amount of protein
synthesized. For example, IgA ASCs in the two salivary glands might process the IgA
mRNAs differently. To quantify the amount of IgA proteins produced by the two
salivary glands, IgA ELISA assays were used. Total protein was extracted from salivary
gland samples, and the protein extracts were used in both ELISA and Bradford assays.
The resultant values from the IgA ELISA assays were normalized to the total amount of
protein in the individual samples. The amounts of IgA per microgram of protein from the
two salivary glands were averaged separately and the SEM was determined. IgA ELISA
assays of the salivary glands of three WT female mice, after normalizing with total
protein content, showed that sublingual gland had an average of 738pg IgA per µg of
protein, while the submandibular gland had only 55 pg IgA per µg protein (Figure 3).
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The result was statistically significant (P= 0.018). The ratio of IgA per µg of protein in
the sublingual gland and the submandibular gland was about 12:1, which was the same as
IgA QPCR results. The results from the QPCR and ELISA assays were consistent.
Immunohistology, QPCR, and ELISA assays all suggested that IgA ASCs accumulated
preferentially in the SLG when compared to the SMG.

Differential expression of chemokines and adhesion molecules in the two salivary
glands
Chemokines can be considered the organizers of the immune system and they
promote the specific localization of lymphocytes into distinct parts in the body. The
mucosal chemokines CCL28 and CCL25 have been shown to mediate the homing of IgA
ASCs into mucosal sites. In an effort to understand the role of these chemokines in the
accumulation of IgA ASCs into the salivary glands, I next examined expression levels of
these chemokines and other mucosal adhesion molecules in the two salivary glands.
QPCR results showed that CCL28 mRNA levels were 2.5 times higher in SLG when
compared with SMG (p<0.01), and the mRNA for the receptor for CCL28, CCR10, was
19 times higher in SLG (p=0.029). On the other hand, SMG expressed 5.5 times more
mRNA for CCL25 (p<0.01) than was present in SLG. Expression levels of the mRNA
for the receptor for CCL25, CCR9, were consistent with the result of CCL25. The SMG
was shown to have 2 times more CCR9 mRNA (p=0.022) than in SLG. The expression
level of CXCL12 mRNA was also higher in the SMG, being expressed almost 3 times
higher than in the SLG (p<0.01). The chemokine CXCL12 is an activator of VCAM-1
binding molecule α4β1(35) and our results showed that SMG had 3.5 times more

20

VCAM-1 mRNA than SLG (p<0.01). However, the expression level of β1 mRNA
contradicted the result from CXCL12 and VCAM-1. Higher level of β1 mRNA was
observed in SLG, which expressed 9 times more than SMG (p=0.016). Interestingly,
MAdCAM-1 mRNA was expressed in very low levels in both salivary glands.
Expression of the MAdCAM-1 binding molecule β7 showed no statistical difference
between the two salivary glands, suggesting that MAdCAM-1 is probably not important
in mediating lymphocyte migration into the glands (Figure 4A and 4B).

CCR10KO mice had similar IgA levels in the two salivary glands
The chemokine and chemokine receptor expression level results showed that in
WT mice the SLG contained high levels of CCL28 and CCR10 mRNA, which correlated
with the higher number of IgA ASCs in that salivary gland. I therefore hypothesized that
the interactions between CCL28 and CCR10 were important in mediating IgA ASCs
migration into the SLG. To test this hypothesis, the levels of IgA ASCs in the two
salivary glands of CCR10KO mice were measured. Based on immunohistology
observations, the numbers of IgA ASCs in the two salivary glands were visually identical.
They both had low numbers of IgA ASCs (Figure 5). IgA QPCR results in CCR10KO
mice showed that IgA mRNA levels were not statistical different between the two
salivary glands (Figure 6). Protein levels, as determined by IgA ELISA assays further
showed that SLG and SMG in CCR10KO mice contained similar amounts of IgA
antibody. In CCR10KO mice, SLG contained only 50 pg IgA per µg protein and SMG
contained 16 pg IgA per µg protein (Figure 7). These results highly suggested that
CCL28/CCR10 interactions play important roles in mediating IgA ASCs homing to SLG.
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Adoptive transfer reconstituted SLG of CCR10KO mice with WT IgA mRNA
IgA QPCR and ELISA results from CCR10KO mice were highly suggestive that
CCL28 mediated the migration of IgA ASCs to the SLG via CCR10. To confirm this, I
performed adoptive transfer experiments, in which splenocytes from WT donor mice
were adoptively transferred into CCR10 deficient recipients. Since CCR10KO salivary
glands should express normal levels of CCL28, introducing WT IgA ASCs that expressed
CCR10 into CCR10KO mice would theoretically reconstitute SLG with higher levels of
IgA ASCs.
Spleen cells, which are rich in lymphocytes, were collected from WT mice and
injected intraperitoneally into CCR10KO mice. Two weeks following adoptive transfer
salivary glands were collected and analyzed for IgA protein and mRNA levels. Control
adoptively transferred CCR10KO mice received the same treatments but with injection of
CCR10KO spleen cells rather than WT cells. The number of IgA ASCs and amount of
IgA in the SLG were compared between the WT and control adoptive transferred groups.
The same comparison was also used to compare SMG in both groups of mice. IgA
QPCR results showed that in SLG, WT adoptively transferred CCR10KO mice had 2.4
times more IgA mRNA than control CCR10KO transferred mice (p=0.01). However,
there was no statistical difference in amount of IgA mRNA in the SMG of the two
adoptively transferred groups. ELISA results confirmed these findings. CCR10KO mice
receiving WT spleen cells produced increased amount of IgA in the SLG, with an
average 80 pg IgA per µg of protein versus 50 pg IgA per µg protein in control KO
transferred mice (p=0.02). IgA protein levels in the SMGs of adoptively transferred mice
showed no statistical differences, as seen in mRNA level (Figure 8). The adoptive
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transfer experiments clearly suggested that CCL28 and CCR10 interaction play a major
role in mediating the migration of CCR10-expressed IgA ASCs into the salivary gland.

Oral CT immunization resulted in increased antigen specific IgA accumulation in
SMG while nasal immunization increased antigen specific IgA in SLG
Since SLG expressed high levels of the “common mucosal chemokine” (27)
CCL28, and SMG expressed high level of intestinal expressing chemokine CCL25, it is
possible that the two salivary glands might attract different subsets of IgA ASCs that
were primed in different mucosal sites. To study the influence of the site of antigen
activation to the migration of IgA ASCs, preliminary experiments were done using mice
which were immunized either orally or nasally. Following immunization the amount of
total IgA and antigen specific IgA were measured in the two salivary glands by ELISA
assays. In the orally immunized group, SMG contained 1.2 ng IgA per µg protein, while
SLG produced an average of 8.8 ng IgA per µg protein (p<0.01). The ratio of total IgA
between SMG and SLG was 1:7.5, which was smaller than the non-immunized WT
(1:12), suggesting SMG had an increased amount of IgA production when compared to
the non-immunized group. On the other hand, in the nasal immunized group, SLG
contained increased amounts of IgA. The SLG of the nasally immunized group contained
11.8 ng IgA per µg protein, while SMG contained 0.2 ng IgA per µg protein (p<0.01).
The ratio of total IgA between the two salivary glands was 1:52.4, which was much
larger than the WT (Figure 9A). These experiments showed that oral immunization
increased total IgA accumulation in SLG.
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In preliminary experiments, aimed at determining antigen specific IgA levels in
the tissues of immunized animals, CT specific ELISA results were calculated as
absorbance at OD 405nm. In the orally immunized group, the absorbance of antigen
specific ELISA assays was 0.017 in the SLG and 0.045 in the SMG. These results
showed no statistical difference between the two salivary glands. In nasally immunized
mice the SLG had a much higher absorbance than SMG. SLG had an average absorbance
0.589, while SMG was 0.133 (p<0.01) (Figure 9B). The results of this CT specific
ELISA suggested that nasal immunization resulted in a preferential accumulation of
antigen specific IgA ASC in the SLG. Oral immunization resulted in a non-statistical
trend toward increased antigen specific IgA in the SMG. These results were highly
suggestive that IgA ASCs migrating to the two salivary glands may be activated in
different mucosal tissues, resulting in different expression patterns of chemokine
receptors and adhesion molecules.
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DISCUSSION
The concept of a common mucosal immune system suggests that IgA ASCs
activated in any one mucosal site have the ability to home to other mucosal surfaces.
Based on this concept, the mucosal sites should have similar homing mechanisms for IgA
ASCs. In this study I showed that within the mouse salivary glands, the number of IgA
ASCs was much higher in SLG when compared to SMG. Three different analysis
methods, immunohistology, QPCR, and ELISA, were used and they all confirmed that
SLG had more IgA than SMG. This observation raised the question: how did one of the
salivary glands come to possess more IgA ASCs than the other? Since chemokines are
the mediators for lymphocyte homing, I hypothesized that the differential expression of
chemokines by the salivary glands contributed to the specific compartmentalization of
IgA ASCs in mouse salivary glands.
CCL28 and CCL25 are two major chemokines that mediate the homing of IgA
ASCs into different mucosal tissues (30) therefore the expression levels of these two
chemokines in the two salivary glands were studied. QPCR results showed differential
expression of the mRNAs for these chemokines and cognate receptors, as well as the
adhesion molecule VCAM-1 in the two salivary glands. Since salivary glands have been
previously shown to express high levels of CCL28 (30), a role for CCL28 in the two
salivary glands was predicted. QPCR results showed that SLG expressed 2.5 times more
CCL28 mRNA than SMG, and CCR10 was 19 times higher in SLG than SMG. The
higher level of CCL28 and CCR10 correlated with the number of IgA ASCs in SLG, and
adoptive transfer experiments were performed which confirmed that CCR10 was indeed
important in attracting IgA ASCs to SLG.
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Although more CCL28 was expressed in SLG, the ratio of the CCL28 mRNA
expressed between the two salivary glands (1:2.5) was much smaller than the mRNA
ratio of CCR10 (1:19) and the level of IgA protein (1:12) in the two glands. The
proportion of CCL28 mRNA represented the amount of chemokine transcription in the
two glands, while the ratio of CCR10 represented the numbers of lymphocytes that
expressed this chemokine receptor, including CCR10 expressing IgA ASCs in the two
salivary glands. These results suggested that the accumulation of CCR10 expressing
cells was not proportional to the level of CCL28 chemokine expression. A possible
explanation could be that there was a threshold of chemokine needed for lymphocytes to
efficiently migrate to, or be retained in a tissue. It could be that when the chemokine
level exceeds that critical mass, lymphocytes would migrate to, and stay in, a tissue. To
test this hypothesis, CCL28 chemotaxis assays could be used, in which numbers of IgA
ASCs migrating to different concentrations of CCL28 are measured and compared. This
experiment may explain why chemokine receptor expression is not proportional to
chemokine levels.
The ratio of CCR10 in the two salivary glands (1:19) was higher than the ratio of
IgA protein (1:12). This discrepancy could be due to lymphocytes other than IgA ASCs
that express CCR10, being recruited into the tissue by the higher concentration of CCL28.
In this study, I only focused on IgA ASC. But to gain a better understanding of the
mucosal immune system in the salivary glands, other cell types such as T cells should
also be studied.
Since the SMG in CCR10KO mice had similar numbers of IgA ASCs as WT mice,
CCR10 interactions with CCL28 seemed to have no effect on IgA migration into SMG.

26

Surprisingly, high expression levels of CCL25 were detected in the SMG. This
chemokine has previously been shown to be selectively expressed by thymus and small
intestinal epithelial cells (31). IgA ASCs localizing in the SMG may be attracted by
CCL25. To test this hypothesis CCR9 KO mice, which have been previously described
could be used. To determine if CCL25 plays a role in IgA ASCs migration to the SMG,
the number of salivary gland IgA ASCs could be measured from the CCR9 KO mouse
and compared to the numbers of IgA ASC found in the SLG of WT mice. If the number
of IgA ASCs is reduced in the SMG of CCR9KO mice, adoptive transfer experiments
could then be performed to confirm that CCR9 interaction with CCL25 are important in
mediating IgA ASCs migration into mouse SMG. Results from such experiments would
not only confirm that the homing of IgA ASCs is highly regulated by differential
expression of tissue specific chemokines, but also demonstrate that the IgA ASCs
migrating to the two salivary glands express different sets of chemokine receptors and
potentially represent different populations of IgA ASCs.
In that CCL28 expression appears to be differentially expressed in the two
salivary glands it brings up the question of what regulates the expression of this
chemokine. It has been reported that enteral stimulation is important in inducing the
expression of CCL28 in small intestine and lung (42). For example, in intravenously fed
animals, CCL28 expression decreased significantly in small intestine and lung when
compared with control mice, suggesting that the expression of this chemokine requires
enteral stimulation (42). Studies by Ogawa et al.(43) demonstrated that the expression
of CCL28 in human colon epithelium can be upregulated by the proinflammatory
cytokines IL-1α and TNF-α, as well as bacterial flagellin, bacterial infection, and n-
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butyrate via a NF-κB activation pathway. Similar CCL28 upregulation patterns are also
observed in human airway epithelial-like cells A549. O’Gorman et al. (44) showed that
IL-1β and TNF-α induced the phosphorylation of NF-kB in the A549 cells, which
resulted in the upregulation of CCL28. These results suggested that CCL28 may function
as an inflammatory chemokine that is regulated by proinflammatory cytokines via NF-kB
pathway. To study the expression mechanism of CCL28 in SLG and SMG, several
experiments could be done. First, the proinflammatory cytokines, such as IL-1, could be
measured and compared between the two salivary glands. Higher levels of these
cytokines may be measured from SLG, which expressed higher levels of CCL28.
Conversely, inhibition of these cytokines in the mouse may alter the expression level of
CCL28. Since the expression of CCL28 is believed to be regulated by the NF-kB
pathway, the second experiment would require the inhibition of NF-kB. If reduced levels
of CCL28 are observed in SLG, the involvement of NF-kB in regulating the expression
of CCL28 in the salivary could be confirmed. Third, since decreased enternal stimulation
reduces CCL28 in small intestine and lung (42), reduction of the CCL28 levels in the two
salivary glands may also observed in the salivary glands. If reduction of CCL28
production appears different in the two salivary glands in parenteral fed animals, it would
further suggest that the two salivary glands serve different functions in the common
mucosal immunological system.
Although CCL25 was discovered before CCL28, not much is known about the
regulation of CCL25 expression. Research by Hermsen et al. (42) has shown that enteral
stimulation is also important for normal CCL25 expression. CCL25 protein level is
significantly reduced when animals were fed intravenously (42). Adding to this
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knowledge, recent research has shown that bile may contribute to the high CCL25 levels
in small intestine (45). CCL25 mRNA is also significantly decreased in animal models
of experimental obstructive jaundice. Ericsson et al. (46) reported that in murine small
intestinal epithelial cells, CCL25 expression is independent of lymphotoxin β receptor
signaling pathway and is not upregulated by inflammatory stimuli. Genetic analysis
further revealed that the CCL25 promoter contains several putative binding sites for the
intestinal epithelial-associated Caudal-related homeobox (Cdx) transcription factors,
suggesting Cdx transcription factors may play regulatory roles for CCL25 expression
(46). Since the SMG expressed similar chemokine profile as in the small intestine, the
regulation mechanism of CCL25 in SMG may also be similar. Reduced CCL25 levels
may be observed in the SMG of parenteral feeding animals.
In this study, QPCR was used to quantify the amount of IgA mRNA and the
expression levels of chemokines, chemokine receptors, and adhesion molecules.
Although QPCR is a highly sensitive method and provides accurate quantitative results
for comparison between the two salivary glands, the properties of each cell type were not
shown. QPCR did not demonstrate the percentage of IgA ASCs that expressed CCR10,
CCR9, or different integrins in each salivary gland. To assess this flow cytometry could
be used. If it shows that one salivary gland has a higher concentration of CCR10 bearing
IgA ASCs, while the other gland has more CCR9 IgA ASCs, it will confirm that the IgA
ASCs migrate to the two salivary glands are indeed different, and that these IgA ASCs
may be primed at different locations and therefore process different sets of chemokine
receptors.
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It has been shown that the small intestine selectively expresses CCL25 and attracts
IgA ASCs expressing CCR9 (33), whereas colon and bronchial tissues express high level
of CCL28 and attract CCR10 expressing IgA ASCs (27). In this study, I showed that
each of the two mouse salivary glands expressed high levels of one of the two IgA ASC
attracting chemokines. Since the mouth is the most common entry site for intestinal
pathogens, localization of IgA ASCs specific for those pathogens in salivary glands
would provide the greatest protection to the body.
The differential accumulation of IgA ASC in the two salivary glands could also be
useful in studying the influence of where a B cell is primed and where it ultimately
localizes. Experiments were performed in which WT mice were immunized with a
specific antigen either orally or nasally. Then the amount of antigen-specific IgA
antibody was measured from the two salivary glands. In preliminary studies I
demonstrated that oral immunization tended to produce more antigen specific IgA in
SMG, while nasal immunization resulted in antigen specific IgA accumulation in SLG.
These preliminary results suggested that the chemokine profiles of each salivary gland
resulted in specific subsets of IgA ASC, defined by site of antigen exposure,
accumulating in each salivary gland.
In this study I have shown that the chemokine expression profile of the SMG and
SLG leads to dramatic differences in the efficiency in which IgA ASC accumulated in the
tissues. Through the use of CCR10KO mice it may now be possible to determine the
physiological importance of IgA ASC accumulation in the SLG. This could be tested by
infecting CCR10KO mice and WT mice with oral pathogens and measuring the
pathogenesis of disease in the two groups of mice. Since there are less IgA ASCs in the
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salivary glands of CCR10KO mice to protect the oral cavity, these mice may have a more
serious case of oral infection than the WT mice. These experiments would show the
importance of localized IgA ASCs in providing tissue specific protection.
In conclusion, I showed that the accumulation of IgA ASC to distinct salivary glands
is a highly selective process dependant on the differential expression of CCL28 and its
interaction with the chemokine receptor CCR10. Furthermore the differential localization
of IgA ASC into different tissues may reflect the site of antigen priming of B cells.
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IgA ASC accumulate preferentially in the SLG compared to the SMG

LN

(A)

SLG

SMG

(B)
SLG

SMG

IgA

Figure 1. Immunohistology of mouse salivary glands cross sections showing that high
concentration of IgA ASCs accumulate in mouse SLG. (A) Immunohistology showing
SLG, SMG and cervical lymph node. High concentration of IgA ASCs (green) was found in
SLG, but not in lymph node, where CD4+ cells (blue) and CD45R cells (red) were found. (B)
Immunohistology with IgA ASCs stained with FITC showing both SLG and SMG. SLG had
higher concentration of IgA ASCs when compared with SMG.
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Figure 2. SLG contains 12 times more IgA mRNA than SMG. QPCR data represent
the mean IgA mRNA levels in the SLG and SMG of 8 WT mice. The result was
statistically significant (**p<0.01) and the bar represents the SEM.
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Amount of IgA per mg of protein in WT mouse salivary
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Figure 3. SLG of WT mice contain 12 fold more IgA protein than SMG. Data
represent the mean protein levels from three WT female mice and the bar depicts
SEM. The result was statistically significant with *p=0.018.
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WT female mice chemokines and addressin expression level in
the two salivary glands
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Figure 4A. Differential expressions of chemokines and vascular addressins in the
salivary glands of wild type mice. SLG expresses 2.5 times more CCL28 than SMG,
while CCL25, CXCL12, and VCAM-1 levels are all higher in SMG. Data represent
the means and the bar depicts the SEM. All data were statistical significant with
**p<0.01.
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WT female mice chemokine receptors and integrin expression
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Figure 4B. Differential expression of chemokine receptors and integrin molecules
in WT mouse salivary glands. CCR10 and β1 were expressed at high levels in SLG,
while CCR9 was high in SMG. β7 showed no differences between the two salivary
glands. Data represent the mean and bar depicts SEM. *p<0.05.
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CCR10KO mice have similar numbers of IgA ASCs in SLG and SMG

LN

Figure 5. Immunohistology showing similar numbers of IgA ASCs in
CCR10KO mouse salivary glands. Similar, low concentrations of IgA ASCs
(green) were found in SLG and SMG. CD45R and CD4 T cell lymphocyte cell
numbers and distribution in the lymph node (upper right corner) was unaffected.
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Amount of IgA mRNA in CCR10KO mouse salivary glands
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Figure 6. IgA mRNA levels are similar in the SLG and SMG in CCR10KO mice.
Data represent the mean IgA mRNA levels from each tissue. Bars represent the SEM.
No statistical differences in the levels of IgA mRNA in the two CCR10KO mouse
salivary glands were observed.
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Amount of IgA per mg of protein in CCR10KO and WT
mouse salivary glands
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Figure 7. IgA protein levels are reduced in CCR10KO mice in SLG and SMG when
compared to WT mouse. (A) In CCR10KO mice SLG IgA protein was found at higher
concentrations than in SMG, but the ratio and the amount were greatly reduced when compared
with WT salivary glands. (B) Comparison of the amount of IgA protein between WT and
CCR10KO salivary glands showed that SLG of CCR10KO mouse produced similar amounts of
IgA to SMG of WT mouse.
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IgA mRNA levels in salivary glands of adoptive transferred
CCR10KO mice
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Figure 8A. Adoptive transfer of WT cells reconstituted the SLG of CCR10KO mice
as measured by increased levels of IgA mRNA. The amount of IgA mRNA in the
SLG was increased when WT lymphocytes were transferred into CCR10KO mice, when
compared to the control group (CCR10KO lymphocytes transferred into CCR10KO
recipients). This increased was not observed in SMG. There was no statistical
difference in the amount of IgA mRNA between the two adoptive transferred groups in
the SMG. *p<0.05
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Figure 8B. SLG of WT transferred CCR10KO mice produced increased
amounts of IgA protein. Adoptively transferred CCR10KO mice, receiving WT
cells, produced higher amounts of IgA when compared to the control group. There
was no statistical different of IgA production in SMG of the two transferred group.
*p<0.05.
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IgA levels in oral and nasal immunized mouse salivary
glands
16

**

Sublingual

ng IgA per mg protein

14
12

Submandibular

**

10
8
6
4
2
0

Oral

Nasal
Immunization methods

Figure 9A. Amount of IgA in the salivary glands of orally and nasally CT immunized
mice. Orally immunization increased the amount of total IgA in SMG and reduced the ratio
of IgA between the two salivary glands from 1:12 in non-immunized WT mice to 1:7.5.
Nasal immunization raised the amount of total IgA in the SLG and enlarged the ratio of IgA
between the two salivary glands to 1:52.4. **p<0.01.
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CT specific IgA levels in the two mouse salivary glands of
oral and nasal immunized mice
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Figure 9B. CT specific IgA levels in mouse salivary glands of orally and
nasally immunized mice. The SMG contained more antigen specific IgA than
SLG after oral immunization while nasal immunization generated more antigen
specific IgA in SLG than in SMG. **p<0.01.

43

REFERENCES
1.
2.

3.

4.
5.

6.

7.

8.

9.

10.

11.
12.

13.
14.

Bienenstock, J., and A. D. Befus. 1980. Mucosal immunology. Immunology
41:249-270.
Bienenstock, J., M. McDermott, D. Befus, and M. O'Neill. 1978. A common
mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp
Med Biol 107:53-59.
Hieshima, K., Y. Kawasaki, H. Hanamoto, T. Nakayama, D. Nagakubo, A.
Kanamaru, and O. Yoshie. 2004. CC chemokine ligands 25 and 28 play essential
roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol
173:3668-3675.
Charles A. Janeway, K. M. M., Paul Travers, Mark Walport. 2007.
Immunobiology. Garland Science.
Gleeson, M., and A. W. Cripps. 2004. Development of mucosal immunity in the
first year of life and relationship to sudden infant death syndrome. FEMS
immunology and medical microbiology 42:21-33.
Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and
cellular interactions involved in IgA biosynthesis and immune response. Adv
Immunol 40:153-245.
Brandtzaeg, P., T. S. Halstensen, K. Kett, P. Krajci, D. Kvale, T. O. Rognum, H.
Scott, and L. M. Sollid. 1989. Immunobiology and immunopathology of human
gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology
97:1562-1584.
Husband, A. J., S. Bao, and K. W. Beagley. 1999. Analysis of the mucosal
microenvironment: factors determining successful responses to mucosal vaccines.
Vet Immunol Immunopathol 72:135-142.
Chintalacharuvu, K. R., J. F. Piskurich, M. E. Lamm, and C. S. Kaetzel. 1991.
Cell polarity regulates the release of secretory component, the epithelial receptor
for polymeric immunoglobulins, from the surface of HT-29 colon carcinoma cells.
J Cell Physiol 148:35-47.
Kobayashi, K., Y. Fujiyama, K. Hagiwara, and H. Kondoh. 1987. Resistance of
normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the
presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and
also in serum IgG. Microbiol Immunol 31:1097-1106.
Kaetzel, C. S. 2005. The polymeric immunoglobulin receptor: bridging innate and
adaptive immune responses at mucosal surfaces. Immunol Rev 206:83-99.
Kett, K., K. Baklien, A. Bakken, J. G. Kral, O. Fausa, and P. Brandtzaeg. 1995.
Intestinal B-cell isotype response in relation to local bacterial load: evidence for
immunoglobulin A subclass adaptation. Gastroenterology 109:819-825.
Gleeson, M., A. W. Cripps, and R. L. Clancy. 1995. Modifiers of the human
mucosal immune system. Immunol Cell Biol 73:397-404.
van Asperen, P. P., M. Gleeson, A. S. Kemp, A. W. Cripps, S. B. Geraghty, C. M.
Mellis, and R. L. Clancy. 1985. The relationship between atopy and salivary IgA
deficiency in infancy. Clin Exp Immunol 62:753-757.

44

15.

16.

17.
18.

19.

20.

21.

22.

23.

24.

25.
26.

27.

28.

Gleeson, M., W. A. McDonald, D. B. Pyne, A. W. Cripps, J. L. Francis, P. A.
Fricker, and R. L. Clancy. 1999. Salivary IgA levels and infection risk in elite
swimmers. Med Sci Sports Exerc 31:67-73.
Gleeson, M., R. L. Clancy, M. J. Hensley, A. W. Cripps, R. L. Henry, J. H.
Wlodarczyk, and P. G. Gibson. 1996. Development of bronchial hyperreactivity
following transient absence of salivary IgA. Am J Respir Crit Care Med
153:1785-1789.
Gleeson, M., A. W. Cripps, R. L. Clancy, J. H. Wlodarczyk, and M. J. Hensley.
1987. IgD in infant saliva. Scand J Immunol 26:55-57.
Mellander, L., B. Carlsson, and L. A. Hanson. 1984. Appearance of secretory IgM
and IgA antibodies to Escherichia coli in saliva during early infancy and
childhood. J Pediatr 104:564-568.
Thrane, P. S., T. O. Rognum, and P. Brandtzaeg. 1991. Ontogenesis of the
secretory immune system and innate defence factors in human parotid glands.
Clin Exp Immunol 86:342-348.
McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal
immunologic system. I. Migration of B immunoblasts into intestinal, respiratory,
and genital tissues. J Immunol 122:1892-1898.
Rudzik, R., R. L. Clancy, D. Y. Perey, R. P. Day, and J. Bienenstock. 1975.
Repopulation with IgA-containing cells of bronchial and intestinal lamina propria
after transfer of homologous Peyer's patch and bronchial lymphocytes. J Immunol
114:1599-1604.
Goldblum, R. M., S. Ahlstedt, B. Carlsson, L. A. Hanson, U. Jodal, G. LidinJanson, and A. Sohl-Akerlund. 1975. Antibody-forming cells in human colostrum
after oral immunisation. Nature 257:797-798.
Weisz-Carrington, P., M. E. Roux, M. McWilliams, P. H.-Q. JM, and M. E.
Lamm. 1979. Organ and isotype distribution of plasma cells producing specific
antibody after oral immunization: evidence for a generalized secretory immune
system. J Immunol 123:1705-1708.
Hue, S., P. Ahern, S. Buonocore, M. C. Kullberg, D. J. Cua, B. S. McKenzie, F.
Powrie, and K. J. Maloy. 2006. Interleukin-23 drives innate and T cell-mediated
intestinal inflammation. J Exp Med 203:2473-2483.
Stein, J. V., and C. Nombela-Arrieta. 2005. Chemokine control of lymphocyte
trafficking: a general overview. Immunology 116:1-12.
Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I.
L. Weissman, A. Hamann, and E. C. Butcher. 1993. Alpha 4 beta 7 integrin
mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.
Cell 74:185-195.
Lazarus, N. H., E. J. Kunkel, B. Johnston, E. Wilson, K. R. Youngman, and E. C.
Butcher. 2003. A common mucosal chemokine (mucosae-associated epithelial
chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 170:37993805.
Hieshima, K., H. Ohtani, M. Shibano, D. Izawa, T. Nakayama, Y. Kawasaki, F.
Shiba, M. Shiota, F. Katou, T. Saito, and O. Yoshie. 2003. CCL28 has dual roles
in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.
J Immunol 170:1452-1461.
45

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

Wang, W., H. Soto, E. R. Oldham, M. E. Buchanan, B. Homey, D. Catron, N.
Jenkins, N. G. Copeland, D. J. Gilbert, N. Nguyen, J. Abrams, D. Kershenovich,
K. Smith, T. McClanahan, A. P. Vicari, and A. Zlotnik. 2000. Identification of a
novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 275:2231322323.
Pan, J., E. J. Kunkel, U. Gosslar, N. Lazarus, P. Langdon, K. Broadwell, M. A.
Vierra, M. C. Genovese, E. C. Butcher, and D. Soler. 2000. A novel chemokine
ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J
Immunol 165:2943-2949.
Kunkel, E. J., J. J. Campbell, G. Haraldsen, J. Pan, J. Boisvert, A. I. Roberts, E. C.
Ebert, M. A. Vierra, S. B. Goodman, M. C. Genovese, A. J. Wardlaw, H. B.
Greenberg, C. M. Parker, E. C. Butcher, D. P. Andrew, and W. W. Agace. 2000.
Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed
chemokine (TECK) expression distinguish the small intestinal immune
compartment: Epithelial expression of tissue-specific chemokines as an
organizing principle in regional immunity. J Exp Med 192:761-768.
Zabel, B. A., W. W. Agace, J. J. Campbell, H. M. Heath, D. Parent, A. I. Roberts,
E. C. Ebert, N. Kassam, S. Qin, M. Zovko, G. J. LaRosa, L. L. Yang, D. Soler, E.
C. Butcher, P. D. Ponath, C. M. Parker, and D. P. Andrew. 1999. Human G
protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively
expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and
thymocytes and is required for thymus-expressed chemokine-mediated
chemotaxis. J Exp Med 190:1241-1256.
Bowman, E. P., N. A. Kuklin, K. R. Youngman, N. H. Lazarus, E. J. Kunkel, J.
Pan, H. B. Greenberg, and E. C. Butcher. 2002. The intestinal chemokine thymusexpressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med
195:269-275.
Hargreaves, D. C., P. L. Hyman, T. T. Lu, V. N. Ngo, A. Bidgol, G. Suzuki, Y. R.
Zou, D. R. Littman, and J. G. Cyster. 2001. A coordinated change in chemokine
responsiveness guides plasma cell movements. J Exp Med 194:45-56.
Glodek, A. M., M. Honczarenko, Y. Le, J. J. Campbell, and L. E. Silberstein.
2003. Sustained activation of cell adhesion is a differentially regulated process in
B lymphopoiesis. J Exp Med 197:461-473.
VanCott, J. L., T. A. Brim, J. K. Lunney, and L. J. Saif. 1994. Contribution of
antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated
with respiratory or enteric strains of coronavirus to immunity against enteric
coronavirus challenge. J Immunol 152:3980-3990.
Johansson, E. L., L. Wassen, J. Holmgren, M. Jertborn, and A. Rudin. 2001.
Nasal and vaginal vaccinations have differential effects on antibody responses in
vaginal and cervical secretions in humans. Infect Immun 69:7481-7486.
Rudin, A., G. C. Riise, and J. Holmgren. 1999. Antibody responses in the lower
respiratory tract and male urogenital tract in humans after nasal and oral
vaccination with cholera toxin B subunit. Infect Immun 67:2884-2890.
Silvers, A. R., and P. M. Som. 1998. Salivary glands. Radiol Clin North Am
36:941-966, vi.

46

40.

41.

42.

43.

44.

45.

46.

Bourges, D., C. H. Wang, C. Chevaleyre, and H. Salmon. 2004. T and IgA B
lymphocytes of the pharyngeal and palatine tonsils: differential expression of
adhesion molecules and chemokines. Scand J Immunol 60:338-350.
Quiding-Jarbrink, M., G. Granstrom, I. Nordstrom, J. Holmgren, and C.
Czerkinsky. 1995. Induction of compartmentalized B-cell responses in human
tonsils. Infect Immun 63:853-857.
Hermsen, J. L., F. E. Gomez, Y. Maeshima, Y. Sano, W. Kang, and K. A. Kudsk.
2008. Decreased enteral stimulation alters mucosal immune chemokines. JPEN J
Parenter Enteral Nutr 32:36-44.
Ogawa, H., M. Iimura, L. Eckmann, and M. F. Kagnoff. 2004. Regulated
production of the chemokine CCL28 in human colon epithelium. Am J Physiol
Gastrointest Liver Physiol 287:G1062-1069.
O'Gorman, M. T., N. A. Jatoi, S. J. Lane, and B. P. Mahon. 2005. IL-1beta and
TNF-alpha induce increased expression of CCL28 by airway epithelial cells via
an NFkappaB-dependent pathway. Cell Immunol 238:87-96.
Matsumoto, T., T. Ajiki, E. Kajiwara, Y. Mita, T. Fujita, H. Morimoto, M.
Miyazawa, and Y. Ku. 2008. Decreased expression of intestinal chemokine
TECK/CCL25 in experimental obstructive jaundice and its reversal following
internal biliary drainage. J Gastroenterol 43:390-396.
Ericsson, A., K. Kotarsky, M. Svensson, M. Sigvardsson, and W. Agace. 2006.
Functional characterization of the CCL25 promoter in small intestinal epithelial
cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription
factors. J Immunol 176:3642-3651.

47

